PARP Inhibitor Biomarkers Market Size, Share, and Growth Forecast for 2025 - 2032

Table of Content

1. Executive Summary
   1. Global PARP Inhibitor Biomarkers Market Snapshot, 2025 and 2032
   2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
   3. Key Market Trends
   4. Future Market Projections
   5. Premium Market Insights
   6. Industry Developments and Key Market Events
   7. PMR Analysis and Recommendations
2. Market Overview
   1. Market Scope and Definition
   2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
   3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
   4. COVID-19 Impact Analysis
   5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   1. Product Adoption Analysis
   2. Regulatory Landscape
   3. Porter’s Five Forces Analysis
   4. PESTLE Analysis
   5. Promotional Strategies, By Key Players
4. Global PARP Inhibitor Biomarkers Market Outlook
   1. Key Highlights
      1. Market Size (US$ Mn) and Y-o-Y Growth
      2. Absolute $ Opportunity
   2. Market Size (US$ Mn) Analysis and Forecast
      1. Historical Market Size (US$ Mn) Analysis, 2019-2023
      2. Current Market Size (US$ Mn) Analysis and Forecast, 2025 - 2032
   3. Global PARP Inhibitor Biomarkers Market Outlook: Product
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Product, 2019 - 2024
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 - 2032
         1. BRCA 1 & 2 Testing Kits
         2. Homologous Recombination Deficiency (HRD) Testing Kits
         3. Homologous Recombination Repair (HRR) Testing Kits
         4. Others
      4. Market Attractiveness Analysis: Product
   4. Global PARP Inhibitor Biomarkers Market Outlook: Application
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn), By Application, 2019 - 2024
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
         1. Ovarian Cancer
         2. Breast Cancer
         3. Others
      4. Market Attractiveness Analysis: Application
   5. Global PARP Inhibitor Biomarkers Market Outlook: End User
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn), By End User, 2019 - 2024
      3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
         1. Hospitals
         2. Pharmaceutical Companies
         3. Diagnostic Laboratories
         4. Academic and Research Institutions
         5. Others
      4. Market Attractiveness Analysis: End User
5. Global PARP Inhibitor Biomarkers Market Outlook: Region
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Region, 2019 - 2024
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2025 - 2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
   4. Market Attractiveness Analysis: Region
6. North America PARP Inhibitor Biomarkers Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Product
      3. By Application
      4. By End User
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. U.S.
      2. Canada
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 - 2032
      1. BRCA 1 & 2 Testing Kits
      2. Homologous Recombination Deficiency (HRD) Testing Kits
      3. Homologous Recombination Repair (HRR) Testing Kits
      4. Others
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
      1. Ovarian Cancer
      2. Breast Cancer
      3. Others
   6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
      1. Hospitals
      2. Pharmaceutical Companies
      3. Diagnostic Laboratories
      4. Academic and Research Institutions
      5. Others
   7. Market Attractiveness Analysis
7. Europe PARP Inhibitor Biomarkers Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Product
      3. By Application
      4. By End User
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 - 2032
      1. BRCA 1 & 2 Testing Kits
      2. Homologous Recombination Deficiency (HRD) Testing Kits
      3. Homologous Recombination Repair (HRR) Testing Kits
      4. Others
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
      1. Ovarian Cancer
      2. Breast Cancer
      3. Others
   6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
      1. Hospitals
      2. Pharmaceutical Companies
      3. Diagnostic Laboratories
      4. Academic and Research Institutions
      5. Others
   7. Market Attractiveness Analysis
8. East Asia PARP Inhibitor Biomarkers Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Product
      3. By Application
      4. By End User
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. China
      2. Japan
      3. South Korea
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 - 2032
      1. BRCA 1 & 2 Testing Kits
      2. Homologous Recombination Deficiency (HRD) Testing Kits
      3. Homologous Recombination Repair (HRR) Testing Kits
      4. Others
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
      1. Ovarian Cancer
      2. Breast Cancer
      3. Others
   6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
      1. Hospitals
      2. Pharmaceutical Companies
      3. Diagnostic Laboratories
      4. Academic and Research Institutions
      5. Others
   7. Market Attractiveness Analysis
9. South Asia & Oceania PARP Inhibitor Biomarkers Market Outlook
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Product
      3. By Application
      4. By End User
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 - 2032
      1. BRCA 1 & 2 Testing Kits
      2. Homologous Recombination Deficiency (HRD) Testing Kits
      3. Homologous Recombination Repair (HRR) Testing Kits
      4. Others
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
      1. Ovarian Cancer
      2. Breast Cancer
      3. Others
   6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
      1. Hospitals
      2. Pharmaceutical Companies
      3. Diagnostic Laboratories
      4. Academic and Research Institutions
      5. Others
   7. Market Attractiveness Analysis
10. Latin America PARP Inhibitor Biomarkers Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
       1. By Country
       2. By Product
       3. By Application
       4. By End User
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
       1. Brazil
       2. Mexico
       3. Rest of Latin America
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 - 2032
       1. BRCA 1 & 2 Testing Kits
       2. Homologous Recombination Deficiency (HRD) Testing Kits
       3. Homologous Recombination Repair (HRR) Testing Kits
       4. Others
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
       1. Ovarian Cancer
       2. Breast Cancer
       3. Others
    6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
       1. Hospitals
       2. Pharmaceutical Companies
       3. Diagnostic Laboratories
       4. Academic and Research Institutions
       5. Others
    7. Market Attractiveness Analysis
11. Middle East & Africa PARP Inhibitor Biomarkers Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
       1. By Country
       2. By Product
       3. By Application
       4. By End User
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
       1. GCC Countries
       2. Egypt
       3. South Africa
       4. Northern Africa
       5. Rest of Middle East & Africa
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 - 2032
       1. BRCA 1 & 2 Testing Kits
       2. Homologous Recombination Deficiency (HRD) Testing Kits
       3. Homologous Recombination Repair (HRR) Testing Kits
       4. Others
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
       1. Ovarian Cancer
       2. Breast Cancer
       3. Others
    6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
       1. Hospitals
       2. Pharmaceutical Companies
       3. Diagnostic Laboratories
       4. Academic and Research Institutions
       5. Others
    7. Market Attractiveness Analysis
12. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
       1. Competition Intensity Mapping By Market
       2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       1. Myriad Genetics, Inc.  
          1. Overview
          2. Segments and Products
          3. Key Financials
          4. Market Developments
          5. Market Strategy
       2. Illumina, Inc.
       3. Amoy Diagnostics Co., Ltd.
       4. QIAGEN
       5. Agilent Technologies, Inc.
       6. Quest Diagnostics Incorporated
       7. Foundation Medicine, Inc.
       8. OncoDNA
       9. 4baseCare
       10. AstraZeneca
       11. Laboratory Corporation of America® Holdings
       12. Genekor | MEDICAL S.A
       13. Cambridge Bioscience Limited
       14. BPS Bioscience, Inc.
       15. BMG Labtech
       16. R&D Systems, Inc (BioTechne)
       17. BellBrook Labs
       18. Abyntek Biopharma S.L.
       19. Epic Sciences
       20. Reaction Biology
13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations